Parameters | Cases | CXCL1 expression | P value | |
---|---|---|---|---|
 |  | Positive (%) | Negative |  |
Gender | ||||
 Male | 41 | 29 (60.1%) | 12 | 0.662 |
 Female | 7 | 4 (57.1%) | 3 |  |
Age | ||||
< 50 | 24 | 13 (54.2%) | 11 | 0.556 |
 ≥50 | 24 | 16 (82.8%) | 8 |  |
Tumor diameter | ||||
< 5°Cm | 35 | 21 (55.4%) | 14 | 1 |
 ≥5°Cm | 13 | 8 (66.7%) | 5 |  |
Tumor number | ||||
Single | 28 | 13 (46.4%) | 15 | 0.394 |
Multiple | 20 | 12 (60.0%) | 8 | Â |
Preoperative AFP(ng/mL) | ||||
<20 | 19 | 8 (57.9%) | 11 | 0.377 |
≥20 | 29 | 17 (58.6%) | 12 |  |
Liver capsule | ||||
Yes | 31 | 11 (35.5%) | 20 | 0.071 |
No | 17 | 11 (64.7%) | 6 | Â |
Distant metastasis | ||||
 Yes | 9 | 7 (77.8%) | 2 | 0.028 |
 No | 39 | 13 (35.6%) | 26 |  |
Clinical TNM stage | ||||
I-II | 37 | 12 (51.4%) | 25 | 0.034 |
III-IV | 11 | 8 (72.7%) | 3 | Â |